Carbamazepine
- Product NDC
- 60687-311
- 11-digit product format
- 606870311
- Labeler code
- 60687
- Product ID
- 60687-311_8efd019e-ced4-2403-e053-2a95a90a849b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA078115
- Marketing category
- ANDA
- Marketing start
- 2019-08-01
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-311-21 | 60687031121 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-311-21) > 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-311-11) | 30 blister pack | 2019-08-01 | 0000-00-00 | No | No | Current |